Calidi Biotherapeutics
Presence
Calidi Biotherapeutics is a company listed under the stock ticker CLDI (US).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Calidi Biotherapeutics
- Allan Camaisa, Chairman of the Board and Chief Executive Officer
- Scott Leftwich, Director
- George Ng, Director
Popular executive movements at Calidi Biotherapeutics
- David LaPré has joined the company as Director (posted on December 12 2023).
- Alan Stewart has joined the company as Director (posted on November 1 2023).
- Tony Kalajian, Interim Chief Financial Officer and Chief Accounting Officer, has left the company (posted on October 30 2023).
Click here to view some more movements at Calidi Biotherapeutics
Create your alert
to follow the executive moves at Calidi Biotherapeutics.
Biotechnology
Calidi Biotherapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Calidi Biotherapeutics
- Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering | Newsroom - Calidi Biotherapeutics
- Stem Cell Platforms for Enhanced Oncolytic Virotherapy | Newsroom - Calidi Biotherapeutics
- Deciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem Cells | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024 | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results | Newsroom - Calidi Biotherapeutics
- Sala de prensa de Calidi | Últimas actualizaciones y avances
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer | Newsroom - Calidi Biotherapeutics
- Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference | Newsroom - Calidi Biotherapeutics
- View more press releases Close
Social media about Calidi Biotherapeutics
- Calidi Biotherapeutics on Wikipedia, Google News & Yahoo Finance
- Calidi Biotherapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Scott Leftwich 
Call Calidi Biotherapeutics at +1 858...
